HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AN 215

consists of 2-pyrrolinodoxorubicin linked to RC-3094
Also Known As:
AN-215
Networked: 15 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Schally, Andrew V: 12 articles (01/2011 - 10/2003)
2. Halmos, Gabor: 9 articles (07/2006 - 10/2003)
3. Nagy, Attila: 9 articles (01/2006 - 10/2003)
4. Keller, Gunhild: 5 articles (07/2006 - 03/2005)
5. Baker, Benjamin: 4 articles (07/2006 - 08/2005)
6. Engel, Jörg B: 4 articles (07/2006 - 03/2005)
7. Szepeshazi, Karoly: 3 articles (01/2006 - 10/2003)
8. Engel, Jorg B: 2 articles (01/2011 - 11/2005)
9. Kanashiro, Celia A: 2 articles (01/2006 - 07/2005)
10. Nagy, A: 2 articles (04/2002 - 11/2000)

Related Diseases

1. Glioblastoma (Glioblastoma Multiforme)
2. Endometrial Neoplasms (Endometrial Cancer)
3. Neoplasms (Cancer)
4. Prostatic Neoplasms (Prostate Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Bombesin
2. AN 238
3. Somatostatin (Somatotropin Release-Inhibiting Factor)
4. P-Glycoproteins
5. AN 204 (AN 201)
6. Gastrin-Releasing Peptide
7. Bombesin Receptors (Bombesin Receptor)
8. Doxorubicin (Adriamycin)
9. Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)
10. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Aftercare (After-Treatment)
4. Investigational Therapies (Experimental Therapy)